Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone.
Jenkins
Amanda J
AJ
Poirier
Joseph G
JG
Juhascik
Matthew P
MP
D002047:Buprenorphine / Q000008:administration & dosage*; D000069479:Buprenorphine, Naloxone Drug Combination; D003429:Cross Reactions; D004338:Drug Combinations; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D009270:Naloxone / Q000008:administration & dosage / Q000276:immunology*; D010098:Oxycodone / Q000276:immunology*; D010349:Patient Compliance
D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D009270:Naloxone; D002047:Buprenorphine; D010098:Oxycodone